Zurück zum Zitat N. Mavaddat, D. Barrowdale, I.L. Andrulis, S.M. Domchek, D. Eccles, H. Nevanlinna, S.J. Ramus, A. Spurdle, M. Robson, M. Sherman, A.M. Mulligan, F.J. Couch, C. Engel, L. McGuffog, S. Healey, O.M. Sinilnikova, M.C. Southey, M.B. Terry, D. Goldgar, F. O'Malley, E.M. John, R. Janavicius, L. Tihomirova, T.V. Hansen, F.C. Nielsen, A. Osorio, A. Stavropoulou, J. Benítez, S. Manoukian, B. Peissel, M. Barile, S. Volorio, B. Pasini, R. Dolcetti, A.L. Putignano, L. Ottini, P. Radice, U. Hamann, M.U. Rashid, F.B. Hogervorst, M. Kriege, R.B. van der Luijt, S. Peock, D. Frost, D.G. Evans, C. Brewer, L. Walker, M.T. Rogers, L.E. Side, C. Houghton, J. Weaver, A.K. Godwin, R.K. Schmutzler, B. Wappenschmidt, A. Meindl, K. Kast, N. Arnold, D. Niederacher, C. Sutter, H. Deissler, D. Gadzicki, S. Preisler-Adams, R. Varon-Mateeva, I. Schönbuchner, H. Gevensleben, D. Stoppa-Lyonnet, M. Belotti, L. Barjhoux, C. Isaacs, B.N. Peshkin, T. Caldes, M. de la Hoya, C. Cañadas, T. Heikkinen, P. Heikkilä, K. Aittomäki, I. Blanco, C. Lazaro, J. Brunet, B.A. Agnarsson, A. Arason, R.B. Barkardottir, M. Dumont, J. Simard, M. Montagna, S. Agata, E. D'Andrea, M. Yan, S. Fox, T.R. Rebbeck, W. Rubinstein, N. Tung, J.E. Garber, X. Wang, Z. Fredericksen, V.S. Pankratz, N.M. Lindor, C. Szabo, K. Offit, R. Sakr, M.M. Gaudet, C.F. Singer, M.K. Tea, C. Rappaport, P.L. Mai, M.H. Greene, A. Sokolenko, E. Imyanitov, A.E. Toland, L. Senter, K. Sweet, M. Thomassen, A.M. Gerdes, T. Kruse, M. Caligo, P. Aretini, J. Rantala, A. von Wachenfeld, K. Henriksson, L. Steele, S.L. Neuhausen, R. Nussbaum, M. Beattie, K. Odunsi, L. Sucheston, S.A. Gayther, K. Nathanson, J. Gross, C. Walsh, B. Karlan, G. Chenevix-Trench, D.F. Easton, A.C. Antoniou, HEBON, EMBRACE, GEMO Study Collaborators, kConFab Investigators, SWE-BRCA Collaborators and Consortium of Investigators of Modifiers of BRCA1/2, Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev 21, 134–147 (2012)CrossRefPubMed
N. Mavaddat, D. Barrowdale, I.L. Andrulis, S.M. Domchek, D. Eccles, H. Nevanlinna, S.J. Ramus, A. Spurdle, M. Robson, M. Sherman, A.M. Mulligan, F.J. Couch, C. Engel, L. McGuffog, S. Healey, O.M. Sinilnikova, M.C. Southey, M.B. Terry, D. Goldgar, F. O'Malley, E.M. John, R. Janavicius, L. Tihomirova, T.V. Hansen, F.C. Nielsen, A. Osorio, A. Stavropoulou, J. Benítez, S. Manoukian, B. Peissel, M. Barile, S. Volorio, B. Pasini, R. Dolcetti, A.L. Putignano, L. Ottini, P. Radice, U. Hamann, M.U. Rashid, F.B. Hogervorst, M. Kriege, R.B. van der Luijt, S. Peock, D. Frost, D.G. Evans, C. Brewer, L. Walker, M.T. Rogers, L.E. Side, C. Houghton, J. Weaver, A.K. Godwin, R.K. Schmutzler, B. Wappenschmidt, A. Meindl, K. Kast, N. Arnold, D. Niederacher, C. Sutter, H. Deissler, D. Gadzicki, S. Preisler-Adams, R. Varon-Mateeva, I. Schönbuchner, H. Gevensleben, D. Stoppa-Lyonnet, M. Belotti, L. Barjhoux, C. Isaacs, B.N. Peshkin, T. Caldes, M. de la Hoya, C. Cañadas, T. Heikkinen, P. Heikkilä, K. Aittomäki, I. Blanco, C. Lazaro, J. Brunet, B.A. Agnarsson, A. Arason, R.B. Barkardottir, M. Dumont, J. Simard, M. Montagna, S. Agata, E. D'Andrea, M. Yan, S. Fox, T.R. Rebbeck, W. Rubinstein, N. Tung, J.E. Garber, X. Wang, Z. Fredericksen, V.S. Pankratz, N.M. Lindor, C. Szabo, K. Offit, R. Sakr, M.M. Gaudet, C.F. Singer, M.K. Tea, C. Rappaport, P.L. Mai, M.H. Greene, A. Sokolenko, E. Imyanitov, A.E. Toland, L. Senter, K. Sweet, M. Thomassen, A.M. Gerdes, T. Kruse, M. Caligo, P. Aretini, J. Rantala, A. von Wachenfeld, K. Henriksson, L. Steele, S.L. Neuhausen, R. Nussbaum, M. Beattie, K. Odunsi, L. Sucheston, S.A. Gayther, K. Nathanson, J. Gross, C. Walsh, B. Karlan, G. Chenevix-Trench, D.F. Easton, A.C. Antoniou, HEBON, EMBRACE, GEMO Study Collaborators, kConFab Investigators, SWE-BRCA Collaborators and Consortium of Investigators of Modifiers of BRCA1/2, Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev
21, 134–147 (2012)
CrossRefPubMed